INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 106 filers reported holding INTERSECT ENT INC in Q1 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $326,000 | -63.0% | 11,657 | -77.3% | 0.13% | -55.2% |
| Q1 2017 | $882,000 | +147.8% | 51,426 | +74.9% | 0.29% | +201.1% |
| Q4 2016 | $356,000 | -70.9% | 29,402 | -68.9% | 0.10% | -57.8% |
| Q2 2016 | $1,224,000 | -54.0% | 94,674 | -16.8% | 0.22% | -12.5% |
| Q3 2015 | $2,662,000 | +114.3% | 113,761 | +162.3% | 0.26% | +112.4% |
| Q2 2015 | $1,242,000 | +41.8% | 43,368 | +27.8% | 0.12% | +40.7% |
| Q1 2015 | $876,000 | – | 33,926 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |